Roche used its September 28, 2026 Pharma Day to move its AI drug-discovery strategy from compute infrastructure into wet-lab automation, outlining an Autonomous Lab Accelerator meant to connect models, robotic experimentation and human review in a closed loop. The plan extends the company's Lab-in-a-Loop program rather than announcing a single finished product, but it puts autonomous experimentation inside Roche's core R&D operating model.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.